Search Results Search Sort by RelevanceMost Recent Policy Forum Sep 2019 How Should Public Health Schools Help Meet Millennium Development Goals in Latin America? Taryn Clark, MD, Julia Terle, MD, and Robert H. Gilman, MD Four MDGs directly concern public health, and public health schools should be involved in meeting them. AMA J Ethics. 2019;21(9):E788-795. doi: 10.1001/amajethics.2019.788. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Viewpoint Nov 2022 What Should “Shopping” Look Like in Actual Practice? Nisha M. Patel, MD, MPH, Jesse M. Ehrenfeld, MD, MPH, and Brian J. Miller, MD, MBA, MPH This article applies principlism to what a “shoppable service” model would demand of clinicians in practice. AMA J Ethics. 2022;24(11):E1099-1106. doi: 10.1001/amajethics.2022.1099. Policy Forum Dec 2006 How Has the Global Fund Affected the Fight against AIDS, Tuberculosis and Malaria? Josh Ruxin, MPH, PhD Virtual Mentor. 2006;8(12):839-842. doi: 10.1001/virtualmentor.2006.8.12.pfor1-0612. Viewpoint Dec 2006 A Caution against Medical Student Tourism Mary Terrell White, PhD and Katherine L. Cauley, PhD Virtual Mentor. 2006;8(12):851-854. doi: 10.1001/virtualmentor.2006.8.12.oped1-0612. Viewpoint Dec 2006 Student Clinical Experiences in Africa: Who Are We Helping? Craig J. Conard, Mark J. Kahn, MD, Karen B. DeSalvo, MD, MPH, MSc, and L. Lee Hamm, MD Virtual Mentor. 2006;8(12):855-858. doi: 10.1001/virtualmentor.2006.8.12.oped2-0612. Policy Forum Feb 2003 Smallpox Vaccination: National Security and Individual Risk Susanna Smith Virtual Mentor. 2003;5(2):57-61. doi: 10.1001/virtualmentor.2003.5.2.pfor2-0302. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Policy Forum Sep 2019 How Should Public Health Schools Help Meet Millennium Development Goals in Latin America? Taryn Clark, MD, Julia Terle, MD, and Robert H. Gilman, MD Four MDGs directly concern public health, and public health schools should be involved in meeting them. AMA J Ethics. 2019;21(9):E788-795. doi: 10.1001/amajethics.2019.788.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Viewpoint Nov 2022 What Should “Shopping” Look Like in Actual Practice? Nisha M. Patel, MD, MPH, Jesse M. Ehrenfeld, MD, MPH, and Brian J. Miller, MD, MBA, MPH This article applies principlism to what a “shoppable service” model would demand of clinicians in practice. AMA J Ethics. 2022;24(11):E1099-1106. doi: 10.1001/amajethics.2022.1099.
Policy Forum Dec 2006 How Has the Global Fund Affected the Fight against AIDS, Tuberculosis and Malaria? Josh Ruxin, MPH, PhD Virtual Mentor. 2006;8(12):839-842. doi: 10.1001/virtualmentor.2006.8.12.pfor1-0612.
Viewpoint Dec 2006 A Caution against Medical Student Tourism Mary Terrell White, PhD and Katherine L. Cauley, PhD Virtual Mentor. 2006;8(12):851-854. doi: 10.1001/virtualmentor.2006.8.12.oped1-0612.
Viewpoint Dec 2006 Student Clinical Experiences in Africa: Who Are We Helping? Craig J. Conard, Mark J. Kahn, MD, Karen B. DeSalvo, MD, MPH, MSc, and L. Lee Hamm, MD Virtual Mentor. 2006;8(12):855-858. doi: 10.1001/virtualmentor.2006.8.12.oped2-0612.
Policy Forum Feb 2003 Smallpox Vaccination: National Security and Individual Risk Susanna Smith Virtual Mentor. 2003;5(2):57-61. doi: 10.1001/virtualmentor.2003.5.2.pfor2-0302.